NCT02332616View on ClinicalTrials.gov

Effect of Methylprednisolone on Complement Activation in Patients Undergoing Total Knee-arthroplasty

PHASE3CompletedINTERVENTIONAL
Enrollment

70

Participants

Timeline

Start Date

January 31, 2015

Primary Completion Date

April 30, 2016

Study Completion Date

April 30, 2016

Conditions
Osteoarthrosis
Interventions
DRUG

Methylprednisolone

Comparison of preoperative single high dose of Methylprednisolone 125 mg iv. and isotonic Sodium Chloride

DRUG

Isotonic Sodium Chloride

Placebo

Trial Locations (1)

2400

Bispebjerg Hospital, Copenhagen NV

All Listed Sponsors
collaborator

Bispebjerg Hospital

OTHER

lead

Rigshospitalet, Denmark

OTHER

NCT02332616 - Effect of Methylprednisolone on Complement Activation in Patients Undergoing Total Knee-arthroplasty | Biotech Hunter | Biotech Hunter